CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression - Takeaways - MDSpire

CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression

  • By

  • Xing Wang

  • Yuhan Tan

  • Ju Wang

  • Ying Kong

  • July 16, 2026

Share

  • 1

    CACUL1 is overexpressed in hepatocellular carcinoma (HCC) and correlates with poor prognosis across 16 tumor types.

  • 2

    CACUL1 knockout inhibits HCC cell proliferation and migration, with transcriptomic analysis revealing PI3K/AKT pathway enrichment.

  • 3

    CACUL1 promotes M2 macrophage polarization through Notch1 suppression, contributing to immune evasion in HCC.

  • 4

    The study utilized pan-cancer analysis, immunohistochemistry, and CRISPR-mediated knockout to investigate CACUL1's role.

  • 5

    CACUL1 is positioned as a potential prognostic biomarker and therapeutic target in hepatocellular carcinoma.

Original Source(s)

CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression

  • by Xing Wang, Yuhan Tan, Ju Wang, Ying Kong

  • July 16, 2026

Related Content

Surviving CGT's Funding Winter

In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market

Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer

Results of applying the 9th edition TNM classification in the staging assessment of nasopharyngeal carcinoma: first data in Vietnam